Aptuit provides cGMP contract pharmaceutical development services to improve development outcomes and simultaneously protect intellectual property. To maximise the success of APIs and formulated products, Aptuit employs polymorph, salt, co-crystal, amorphous materials and analytical method development research.
Aptuit offers analytical method development for the isolation, identification and characterisation of proteins and other large molecules. Aptuit’s method of exploring the solid-state properties of biomolecules leads to faster development and improved products as well as greater control and reproducibility. Aptuit offers well established problem solving expertise for drug substance and product development, stability, analytical methods, intellectual property and diverse solid-state chemistry control issues.